title: The impact of pharmacovigilance on drug portfolio management.
abstract: This review examines the influence of pharmacovigilance on drug portfolio. As a result of pharmacovigilance studies, actions are taken by national drug administrations and/or the World Health Organization (WHO) that have a strong impact on drug portfolio management: drug withdrawal from medical practice, discovery of new therapeutic indications, discovery of drug interactions, preference for specific pharmaceutical formulations, discovery of contraindications and change of drug prescription status.
authors: Neurology at Klinikum Ansbach, Ansbach, Germany. s_bucurescu@yahoo.com.
authors: S
authors: S
authors: Bucurescu
mesh_terms: D002626:Chemistry, Pharmaceutical; D004347:Drug Interactions; D011307:Drug Prescriptions; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D006801:Humans; D060735:Pharmacovigilance; D056737:Safety-Based Drug Withdrawals; D014944:World Health Organization